JNJ-0284

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameJNJ-0284
Drug Alias NameJNJ-0284
ClassificationOther
Mechanisms of ActionSynuclein alpha modulatorsGlutamate receptor ionotropic AMPA modulators
TargetsGlutamate receptor ionotropic AMPASynuclein alpha
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesJohnson & Johnson
Inactive CompaniesN/A
Active IndicationsNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A